MapLight Therapeutics, Inc.
MPLT
$28.00
-$1.27-4.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 165.35% | 112.95% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 140.88% | 103.84% | -- | -- | -- |
| Operating Income | -140.88% | -103.84% | -- | -- | -- |
| Income Before Tax | -146.32% | -107.72% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -146.32% | -107.72% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -146.32% | -107.72% | -- | -- | -- |
| EBIT | -140.88% | -103.84% | -- | -- | -- |
| EBITDA | -142.22% | -104.88% | -- | -- | -- |
| EPS Basic | 24.89% | -2.36% | -- | -- | -- |
| Normalized Basic EPS | 25.59% | -1.91% | -- | -- | -- |
| EPS Diluted | 24.89% | -2.36% | -- | -- | -- |
| Normalized Diluted EPS | 25.59% | -1.91% | -- | -- | -- |
| Average Basic Shares Outstanding | 2,501.02% | 1,070.52% | -- | -- | -- |
| Average Diluted Shares Outstanding | 2,501.02% | 1,070.52% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |